Oncology & Cancer

Scientists explore potential new treatments for glioblastoma

A new approach to treating the most malignant type of brain cancer—glioblastoma—has shown strong promise in pre-clinical settings, raising hopes of increasing current average survival rates beyond 18 months.

Oncology & Cancer

Q&A: New strategy can improve cell therapy against cancer

Researchers at the Center for Infectious Medicine at the Department of Medicine, Huddinge have developed a new strategy that can make cell therapy against cancer work longer in patients. The results are published in the journal ...

page 3 from 4